This package also includes:
Algeria / 110,711+ cases
China donates 200,000 Sinopharm doses as vaccination campaign begins. Local production of Russian vaccine Sputnik-V planned for later this year.
Bahrain / 112,742+ cases
Sputnik-V vaccine becomes fourth jab approved in the country after Pfizer-BioNTech, Sinopharm, and Oxford-AstraZeneca.
Egypt / 173,813+ cases
President Abdul Fattah el-Sisi says “the money is available” for vaccines and “there is no problem”.
Iraq / 643,852+ cases
Health Minister Hassan al-Tamimi says the country will receive 2.5-3 million doses of coronavirus vaccine by the end of February.
Jordan / 347,250+ cases
Amman discusses procurement of Sputnik-V vaccine for citizens and refugees with Russia.
Kuwait / 177,701+ cases
Local media has reported that Kuwait planned to receive its fifth batch of the Pfizer-BioNTech vaccine in February.
Lebanon / 339,129+ cases
Vaccination rollout is under way following the arrival of the first batch of the Pfizer-BioNTech jabs in mid-February.
Libya / 127,705+ cases
Local media reports that Libya has secured 55,000 Pfizer and 920,000 Oxford-AstraZeneca vaccine doses.
Morocco / 478,474+ cases
Rabat receives 2 million doses of Oxford-AstraZeneca’s vaccine from India as the country’s inoculation programme gets under way.
Oman / 137,592+ cases
Administration of second dose of Pfizer-BioNTech’s vaccine begins for groups including those aged over
Qatar / 157,244+ cases
National Covid-19 vaccination programme begins with a focus on high-risk groups such as the elderly.
Saudi Arabia / 372,732+ cases
Imam Abdul Rahman bin Faisal University starts first phase clinical trials with the Education Ministry to produce a Covid-19 vaccine.
Syria / 14,863+ cases
Local media reports that the WHO plans to roll out Covid-19 vaccines across Syria from April.
Tunisia / 223,244+ cases
First batch of 93,600 Pfizer-BioNTech doses expected in March, according to Ahlem Gzara, a member of the national vaccination committee.
UAE / 351,895+ cases
More than 5.5 million doses administered as of 20 February. Vaccines approved for use include Sinopharm, Pfizer-BioNTech, Sputnik-V, and Oxford-AstraZeneca.
A MEED Subscription...
Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.